Literature DB >> 7024060

Characteristic distribution of immunoglobulin-containing cells in palatine tonsils.

J Franĕk, V Kubín, V Novák, J Bedka.   

Abstract

Using fluorescein-labelled antibodies against gamma, mu and alpha chains, Ig-containing cells in palatine tonsils were studied in 120 patients. The aim of this study was to determine the most frequently repeated typical findings as regards the numbers and localisation of these cells in tonsils and to confront the data obtained with the concept that tonsils are a component of the local immunity system. The preponderance of IgG over IgA cells was confirmed, both cell types being preferentially localized in extrafollicular tissue whereas IgM was mostly found in germinal centres. Together with progressing tonsillar atrophia, the frequency of positive findings of IgM decreased, whereas the numbers of IgG and IgA cells were proportional to the amount of remaining lymphoid tissue. IgA cells were not preponderant in tonsils and their localization in the surface layer of epithelium was rather exceptional, SC antigen could not be demonstrated unequivocally and the morphological picture in germinal centres was characteristic for IgM production rather for IgA. Thus the palatine tonsils according to the content and distribution of immunocytes, correspond to the lymph node rather than to an organ involved significantly in the local antibody formation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7024060     DOI: 10.1007/bf02927432

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  15 in total

1.  Immunoglobulin systems of human tonsils. I. Control subjects of various ages: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations.

Authors:  P Brandtzaeg; L Surjan; P Berdal
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

2.  [Observation of the localization of gamma-1A-globulin in the skin and mucosa in relation to allergic reactions].

Authors:  V Pesák; V Hlasivcová
Journal:  Cas Lek Cesk       Date:  1966-08-09

3.  Distribution in human nasopharyngeal tonsils of plasma cells containing different types of immunoglobulin polypeptide chains.

Authors:  P A Crabbé; J F Heremans
Journal:  Lab Invest       Date:  1967-01       Impact factor: 5.662

4.  Localization of 11 S external secretory IgA by immunofluorescence in tissues lining the oral and respiratory passages in man.

Authors:  R D Rossen; C Morgan; K C Hsu; W T Butler; H M Rose
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

5.  The IgA system. II. The clinical significance of IgA deficiency: studies in patients with agammaglobulinemia and ataxia-telangiectasia.

Authors:  M A South; M D Copper; F A Wollheim; R A Good
Journal:  Am J Med       Date:  1968-02       Impact factor: 4.965

6.  Co-operation between T and B lymphocytes from human tonsils in the response to mitogens and antigens.

Authors:  S Romagnani; E Maggi; A Amadori; M G Giudizi; M Ricci
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

7.  [The pharyngeal lymphoid tissue in children. Data given by immunofluorescent study].

Authors:  N Diebold; C Nezelof
Journal:  Presse Med       Date:  1971-10-30       Impact factor: 1.228

8.  Immunoglobulin-containing cells in human tonsils as demonstrated by immunohistochemistry.

Authors:  R C Curran; E L Jones
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

9.  Immunoglobulin systems of human tonsils. II. Patients with chronic tonsillitis or tonsillar hyperplasia: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations.

Authors:  L Surjan; P Brandtzaeg; P Berdal
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

10.  Differentiated B lymphocytes. Potential to express particular antibody variable and constant regions depends on site of lymphoid tissue and antigen load.

Authors:  P J Gearhart; J J Cebra
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.